“Off” painful dystonia in Parkinson's disease treated with botulinum toxin
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The “off” painful dystonia (OPD), usually concerning the feet, is a type of abnormal involuntary movement, induced by the chronic use of levodopa. It is mostly observed in the advanced stage of Parkinson's disease (PD), particularly in the early morning, in the evening, and late at night. Indeed, some patients have experienced OPD also during “on” periods when dystonic posture of the foot alternates with dyskinesia. The pain probably is due to sustained muscle contraction, which causes prolonged muscle spasm, as in primary dystonia or torticollis. Dopaminergic drugs like bromocriptine, pergolide, and especially apomorphine (s. c., infusions, or bolus), can dramatically improve the OPD. Anticholinergics baclofen and lithium are also used in the management of OPD with some benefit. On the other hand, clinical experience shows that in many cases, these therapeutic procedures are not always enough to produce the expected results. Thirty PD patients (22 men and eight women) with OPD of the foot were treated with botulinum toxin (Botox, Btx) using electromyograms to guide injections. Dystonia was evaluated using a quantitative rating scale. The selection of the muscles for Btx treatment was carried out on the basis of foot posture. We injected Btx into tibialis posterior, tibialis anterior, gastrocnemius, flexor digitorum longus, and extensores hallucis longus with a median dose 40 IU for each muscle, distributed in two sites. In all patients, the pain improved within 10 days, whereas in 21 patients, the pain disappeared completely for 4 months (range, 3–7 months); a concomitant improvement in intensity of the dystonic spasm was also observed. No side effects were reported. Seven patients with associated “on” foot dystonia described an improvement of foot posture on walking. In conclusion, in this uncontrolled study, the use of Btx in OPD seemed a promising tool to improve pain linked to foot dystonia; however, because of the well‐known underlying dopaminergic defect in OPD, the Btx therapy should be considered only if the dopaminergic treatment established for the management of OPD has failed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dystonia in parkinson's disease: Clinical and pharmacological features
Poewe, W. H., Lees, A. J., & Stern, G. M. (1988) · Annals of Neurology · doi:10.1002/ana.410230112 · Cited by 162
The Pharmacology of Foot Dystonia in Parkinsonism
Poewe, W. H., & Lees, A. J. (1987) · Clinical Neuropharmacology · doi:10.1097/00002826-198702000-00004 · Cited by 28
Cited by
Ford, B. (2010) · Movement Disorders · doi:10.1002/mds.22716 · Cited by 374
Jankovic, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70574-9 · Cited by 332
Jankovic, J., & Tintner, R. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00025-6 · Cited by 135
Pain in Parkinson's disease: Common yet seldom recognized symptom is treatable
Waseem, S., & Gwinn-Hardy, K. (2001) · Postgraduate Medicine · doi:10.3810/pgm.2001.12.1063 · Cited by 54
Botulinum toxin treatment for functional disability induced by essential tremor
Pacchetti, C., Mancini, F., Bulgheroni, M., Zangaglia, R., Cristina, S., Sandrini, G., & Nappi, G. (2000) · Neurological Sciences · doi:10.1007/s100720070049 · Cited by 48
Self-citation
Metadata
- Authors
- Pacchetti, C., Albani, G., Martignoni, E., Godi, L., Alfonsi, E., & Nappi, G.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 1995-05
- Volume
- 10
- Issue
- 3
- Pages
- 333-336
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W1992298761
- Cited by
- 116
- References
- 2
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.